Evaluation of the Pharmacokinetic Interaction between Lesogaberan (AZD3355) and Esomeprazole in Healthy Subjects

Background: Transient lower esophageal sphincter relaxations (TLESRs) have been identified as a primary cause of reflux events in patients with gastroesophageal reflux disease (GERD). GABAB receptor agonists such as lesogaberan (AZD3355) have been shown to inhibit TLESRs in healthy subjects and pati...

Full description

Bibliographic Details
Main Authors: Niazi, Mohammad, Silberg, Debra G., Miller, Frank, Ruth, Magnus, Holmberg, Ann A.
Format: Online
Language:English
Published: Springer International Publishing 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586101/